Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Scientists Uncover Surprising Mechanism Behind Antibiotic-Resistant Bacteria

August 24, 2015 10:35 am | by The Scripps Research Institute | News | Comments

Every year, more strains of bacteria develop resistance to the antibiotics we use to treat deadly infections. At The Scripps Research Institute (TSRI) scientists have been working to develop new forms of these drugs, including an antibiotic called arylomycin—but tests have shown that it is possible for bacteria to become resistant to arylomycin, too. Read more...


Second Cancers Are on the Rise; 1 In 5 U.S. Cases Is a Repeat

August 24, 2015 10:08 am | by Marilynn Marchione, AP Medical Writer | News | Comments

Second cancers are on the rise. Nearly 1 in 5 new cases in the U.S. now involves someone who has had the disease before. Read more...


Powdered Cranberry Combats Colon Cancer in Mice

August 24, 2015 9:58 am | by American Chemical Society | News | Comments

Cranberries are often touted as a way to protect against urinary tract infections, but that may be just the beginning. Researchers fed cranberry extracts to mice with colon cancer and found that the tumors diminished in size and number. Read more...


A Bridge for Promising Research

August 24, 2015 9:32 am | by Harvard University | News | Comments

A dozen accelerator grants help cover biomedical development gap. Read more...


Researchers Set to Develop New Diabetes Treatment

August 24, 2015 8:49 am | by University of Otago | News | Comments

The team will use their Proof of Concept Grant to progress their product to commercialization. Read more...


With Many Ebola Survivors Ailing, Doctors Evaluate Situation

August 24, 2015 8:40 am | by Carley Petesch, Associated Press | News | Comments

Lingering health problems afflicting many of the roughly 13,000 Ebola survivors have galvanized global and local health officials to find out how widespread the ailments are, and how to remedy them. Read more...


Novartis to Spend $1B on Rights to GSK's MS Drug

August 24, 2015 8:30 am | by Ryan Bushey, Associate Editor | News | Comments

Novartis initially acquired the rights to the drug earlier this year for treating cancer. Read more...


EMA Accepts Takeda's Marketing Authorization Application for Ixazomib

August 24, 2015 8:00 am | News | Comments

Additional filings in other countries are planned to begin later this fiscal year. Read more...


Imperfect Test Fuels Alternative Treatments for Lyme Disease

August 24, 2015 7:45 am | by Matthew Perrone, AP Health Writer | News | Comments

Lyme disease conjures memories of checking for ticks at camp and fretting over bug bites after hikes in the woods. Read more...


Surge in Flu This Winter

August 24, 2015 7:30 am | by University of Sydney | News | Comments

Figures from NSW Health indicate the number of outbreaks that have involved "type B" influenza are far higher than last year. Read more...


Pfizer Announces Positive Topline Results Of Two Phase 3 Studies Of Trumenba

August 21, 2015 12:09 pm | News | Comments

Pfizer Inc. announced today positive topline results of two Phase 3 studies of Trumenba (Meningococcal Group B Vaccine). One study included approximately 3,600 healthy individuals 10 through 18 years of age, and the other study included approximately 3,300 healthy individuals 18 through 25 years of age. Read more...


Protein Found to Control Inflammatory Response

August 21, 2015 11:59 am | by Northwestern University | News | Comments

A new Northwestern Medicine study shows that a protein called POP1 prevents severe inflammation and, potentially, diseases caused by excessive inflammatory responses. Read more...

New Center Will Advance Life-Saving Genome-Based Diagnostic Tools

August 21, 2015 11:50 am | by UCSF | News | Comments

Building on its pioneering research into the use of genomic technology to rapidly diagnose life-threatening diseases, UC San Francisco has launched a dedicated research center to explore how this potentially transformative approach to critical care medicine could be widely integrated into healthcare settings. Read more...


Diabetes Drug Shows 1st Protection from Heart Complications

August 21, 2015 11:39 am | by Linda A. Johnson, AP Business Writer | News | Comments

For the first time, there's evidence that a diabetes medication, Jardiance, reduces risk of the complications that are the top killer of diabetics: heart attacks, strokes and other cardiovascular damage. Read more...

Drug Discovery Spotlight: FDA Approves Flibanserin (Addyi)

August 21, 2015 11:07 am | by Stephanie Guzowski, Editor | News | Comments

Welcome to Drug Discovery Spotlight, where we've rounded up the most popular headlines from the week. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.